EMERALD HEALTH THERAPEUTICS, INC ("EMH")
BULLETIN TYPE: Prospectus-Unit Offering
BULLETIN DATE: February 8, 2018
TSX Venture Tier 1 Company
Effective February 7, 2018, the Company's Shelf Prospectus Supplement dated January 5, 2018 was filed with and accepted by TSX Venture Exchange. The units were offered by way of a Shelf Prospectus Supplement filed in all of the provinces of Canada, except Quebec, pursuant to National Instrument 44-101.
TSX Venture Exchange has been advised that closing occurred on January 9, 2018, for gross proceeds of $15,000,000.
Underwriters: None
Offering: 3,000,000 units. Each unit consisting of one common share and one common share purchase warrant. Each warrant will entitle the holder to acquire one common share at an exercise price of $6.00 for a period of 36 months from the Closing date, subject to acceleration.
Unit Price: $5.00 per unit.
Warrant Exercise Price/Term: $6.00 per share to January 9, 2021.
Compensation Options: None
For further information, please see the Company's news release's dated January 9, 2018.
_______________________________________
|
|
